PerkinElmer, Inc.
Jan 20, 2014
PDF

PerkinElmer Introduces Novel Research Tools to Accelerate Discovery of More Effective Therapies for Life Threatening Diseases at the Society for Laboratory Automation and Screening (SLAS) 2014 Conference

SAN DIEGO, CA – January 20, 2014 PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, will introduce several novel products at the third Annual Society for Laboratory Automation and Screening (SLAS) Conference (#SLAS2014) in San Diego, January 18-22, including the Opera® Phenix™ high content screening system, JANUS® chemagic nucleic acid workstation (Booth #1005).

"We are excited to participate in this important event for our industry as we continue to listen and learn from our customers, helping advance transformative science and build upon a legacy of innovation in automation, detection and screening solutions,” said Jim Corbett, President, Life Sciences and Technology, PerkinElmer. "Advances in phenotyping complex cellular models and innovations in genomics, particularly rapid, high throughput nucleic acid extraction, offer new tools to accelerate our understanding of cancer and other life threatening diseases, as well as enable customers to bring better, more effective therapeutics to market."

PerkinElmer products on display at SLAS 2014 include:

The above products are for research use only and not for use in diagnostic procedures.



About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.1 billion in 2012, has about 7,600 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

###

 

Media Contact:

Nancy Hertig
Nancy.hertig@perkinelmer.com
781-266-7459